177 related articles for article (PubMed ID: 31213754)
1. Gram-negative bacteria as emerging pathogens affecting mortality in skin and soft tissue infections.
Ioannou P; Tsagkaraki E; Athanasaki A; Tsioutis C; Gikas A
Hippokratia; 2018; 22(1):23-28. PubMed ID: 31213754
[TBL] [Abstract][Full Text] [Related]
2. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
3. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
Turina M; Cheadle WG
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
[TBL] [Abstract][Full Text] [Related]
4. A practical guide to the treatment of complicated skin and soft tissue infections.
Fung HB; Chang JY; Kuczynski S
Drugs; 2003; 63(14):1459-80. PubMed ID: 12834364
[TBL] [Abstract][Full Text] [Related]
5. [Skin and soft-tissue infections in hospitalized patients: epidemiology, microbiological, clinical and prognostic factors].
Raya-Cruz M; Ferullo I; Arrizabalaga-Asenjo M; Nadal-Nadal A; Díaz-Antolín MP; Garau-Colom M; Payeras-Cifre A
Enferm Infecc Microbiol Clin; 2014 Mar; 32(3):152-9. PubMed ID: 23683754
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
Lee SY; Kuti JL; Nicolau DP
Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
[TBL] [Abstract][Full Text] [Related]
7. Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai.
Phakade RS; Nataraj G; Kuyare SS; Khopkar US; Mehta PR
J Postgrad Med; 2012; 58(1):3-7. PubMed ID: 22387641
[TBL] [Abstract][Full Text] [Related]
8. Newer treatment options for skin and soft tissue infections.
Raghavan M; Linden PK
Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
[TBL] [Abstract][Full Text] [Related]
9. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
[TBL] [Abstract][Full Text] [Related]
10. Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
Sader HS; Jones RN; Silva JB;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):281-8. PubMed ID: 12493176
[TBL] [Abstract][Full Text] [Related]
11. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).
Doern GV; Jones RN; Pfaller MA; Kugler KC; Beach ML
Diagn Microbiol Infect Dis; 1999 May; 34(1):65-72. PubMed ID: 10342110
[TBL] [Abstract][Full Text] [Related]
12. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.
Ray GT; Suaya JA; Baxter R
Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
Hau T
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).
Rennie RP; Jones RN; Mutnick AH;
Diagn Microbiol Infect Dis; 2003 Apr; 45(4):287-93. PubMed ID: 12730001
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics for skin and soft tissues infections in type 2 diabetes mellitus.
Butranova OI; Razdrogina TN
Int J Risk Saf Med; 2015; 27 Suppl 1():S57-8. PubMed ID: 26639712
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
17. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of SSTI and role of tigecycline].
Concia E
Infez Med; 2009 Sep; 17 Suppl 4():64-76. PubMed ID: 20428022
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of epidemiology and antimicrobial resistance of gram-negative bacterial bloodstream infections in children].
Dong L; Zhang XY; Li CC; Li Z; Xia YQ
Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):683-688. PubMed ID: 28881515
[No Abstract] [Full Text] [Related]
20. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
Pfaller MA; Jones RN; Doern GV; Sader HS; Kugler KC; Beach ML
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):283-97. PubMed ID: 10212756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
